Search results
EnWave Reports 2024 Second Quarter Consolidated Interim Financial Results
Digital Journal· 2 days agoVANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial ...
Want to Fully Protect Your Brand? Don’t Forget the Coffee Mugs! | JD Supra
JD Supra· 6 days agoAs long as such goods are not needed or useful for the trademark owner to provide other services and have value to the user, these items pass the U.S. Patent and Trademark ...
IP Considerations For Companies In Carbon Capture Sector | JD Supra
JD Supra· 6 days agoWhen thinking of archetypal unicorns in the technology sector, carbon capture is rarely top of mind. Because carbon capture technologies are multidisciplinary in nature, collaborations between ...
JD Supra: What’s Trending in Trademarks, April 2024: Chile/Chili Crunch, Jelly Roll, and Seltzer...
JD Supra· 2 days agoCelebrity chef David Chang, founder of the Momofuku restaurant and food brand, announced this month that he and his company would no longer continue the controversial enforcement of its trademarks ...
Eupraxia Pharmaceuticals Announces New Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for...
WROC Rochester· 5 days agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a...
Eupraxia Pharmaceuticals Announces Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment...
FOX21 Colorado Springs· 3 days agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize ...
American Resources Corporation Reports First Quarter 2024 Financial Results and Provides Business...
Digital Journal· 5 days agoCompany successfully executed and closed $150 million tax exempt bond offering for the Company's Kentucky Lithium refining facilityThe first domestic, commercial producer of separated and high-purity ...
Tom Still: From the lab to promising drugs, WARF Therapeutics aims to quickly lever research
Wisconsin State Journal· 6 days agoIf you’ve lived in Wisconsin long enough, you’ve likely heard the complaint. One recent example is...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize ...
A New Era of Influence: A Swift Take on Branding, Computer-Generated Influencers and Deepfakes |...
Law.com· 6 days agoA household name for her music and sold-out concerts, Swift is known for leveraging intellectual...